Current Diabetes Reports最新文献_第7页

Precision Interventions Targeting the Maternal Metabolic Milieu for Healthy Pregnancies in Obesity. 针对母体代谢环境进行精准干预，促进肥胖孕妇健康怀孕。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-10-01 Epub Date: 2024-08-20 DOI: 10.1007/s11892-024-01550-6

Alexandra M Niclou, Hannah E Cabre, Emily W Flanagan, Leanne M Redman

{"title":"Precision Interventions Targeting the Maternal Metabolic Milieu for Healthy Pregnancies in Obesity.","authors":"Alexandra M Niclou, Hannah E Cabre, Emily W Flanagan, Leanne M Redman","doi":"10.1007/s11892-024-01550-6","DOIUrl":"10.1007/s11892-024-01550-6","url":null,"abstract":"Purpose of review: Entering pregnancy with obesity increases the risk of adverse health outcomes for parent and child. As such, research interventions are largely focused on limiting excess gestational weight gain during pregnancy, especially in those with obesity. Yet, while many lifestyle interventions are successful in reducing GWG, few affect pregnancy outcomes. Here we review work targeting the metabolic milieu instead of focusing solely on weight.Recent findings: Work done in non-pregnant populations suggests that specifically targeting glucose, triglyceride, and leptin levels or inflammatory makers improves the metabolic milieu and overall health. We posit that precision interventions that include strategies such as time restricted eating, following the 24 h movement guidelines, or reducing sedentary behavior during pregnancy can be successful approaches benefiting the maternal metabolic milieu and minimize the risk of adverse pregnancy outcomes. Personalized tools such as continuous glucose monitors or community-based approaches play an important role in pre-conception health and should be extrapolated to pregnancy interventions to directly benefit the metabolic milieu optimizing health outcomes for both parent and child.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"227-235"},"PeriodicalIF":5.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036336/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion. ABCC8相关青年成熟期发病糖尿病（ABCC8-MODY）的神秘性。文献综述与病例讨论。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-09-01 Epub Date: 2024-07-09 DOI: 10.1007/s11892-024-01547-1

Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Paolo Fadini

{"title":"The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion.","authors":"Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro, Gian Paolo Fadini","doi":"10.1007/s11892-024-01547-1","DOIUrl":"10.1007/s11892-024-01547-1","url":null,"abstract":"Purpose of review: Maturity-onset diabetes of the young (MODY) are monogenic forms of diabetes resulting from genetic defects, usually transmitted in an autosomal dominant fashion, leading to β-cell dysfunction. Due to the lack of homogeneous clinical features and univocal diagnostic criteria, MODY is often misdiagnosed as type 1 or type 2 diabetes, hence its diagnosis relies mostly on genetic testing. Fourteen subtypes of MODY have been described to date. Here, we review ABCC8-MODY pathophysiology, genetic and clinical features, and current therapeutic options.Recent findings: ABCC8-MODY is caused by mutations in the adenosine triphosphate (ATP)-binding cassette transporter subfamily C member 8 (ABCC8) gene, involved in the regulation of insulin secretion. The complexity of ABCC8-MODY genetic picture is mirrored by a variety of clinical manifestations, encompassing a wide spectrum of disease severity. Such inconsistency of genotype-phenotype correlation has not been fully understood. A correct diagnosis is crucial for the choice of adequate treatment and outcome improvement. By targeting the defective gene product, sulfonylureas are the preferred medications in ABCC8-MODY, although efficacy vary substantially. We illustrate three case reports in whom a diagnosis of ABCC8-MODY was suspected after the identification of novel ABCC8 variants that turned out to be of unknown significance. We discuss that careful interpretation of genetic testing is needed even on the background of a suggestive clinical context. We highlight the need for further research to unravel ABCC8-MODY disease mechanisms, as well as to clarify the pathogenicity of identified ABCC8 variants and their influence on clinical presentation and response to therapy.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"197-206"},"PeriodicalIF":5.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lifestyle Intervention in Reducing Insulin Resistance and Preventing type 2 Diabetes in Asia Pacific Region: A Systematic Review and Meta-Analysis. 亚太地区减少胰岛素抵抗和预防 2 型糖尿病的生活方式干预：系统回顾与元分析》。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI: 10.1007/s11892-024-01548-0

Yingting Cao, Abha Shrestha, Amy Janiczak, Xia Li, Yang Lu, Tilahun Haregu

{"title":"Lifestyle Intervention in Reducing Insulin Resistance and Preventing type 2 Diabetes in Asia Pacific Region: A Systematic Review and Meta-Analysis.","authors":"Yingting Cao, Abha Shrestha, Amy Janiczak, Xia Li, Yang Lu, Tilahun Haregu","doi":"10.1007/s11892-024-01548-0","DOIUrl":"10.1007/s11892-024-01548-0","url":null,"abstract":"Purpose of review: To update the evidence of lifestyle interventions for the prevention of type 2 diabetes mellites (T2DM) in adults, particularly in the Asia Pacific region. The key questions to ask are: 1) How effective are lifestyle interventions in preventing T2DM among at-risk adults in the Asia Pacific Region? 2)What are the key characteristics of the implementation of lifestyle interventions for diabetes prevention?Recent findings: Lifestyle interventions for the prevention of T2DM have been suggested to be effective. There is evidence of ethnic differences in some glycaemic and anthropometric outcomes. The meta-analysis suggested a significant result in reducing waist circumference (standardised mean difference - 019, 95%CI ( -0.31, -0.06)), and no significant effects in other outcomes. However, the implementation outcomes suggested lifestyle intervention might be a cost-effective and sustainable approach in T2DM particularly in countries in the Asia Pacific Region. The focus of lifestyle intervention in the Asia Pacific Region should not only lie in the effectiveness of the trial but a thorough evaluation of the implementation outcomes, as well as cultural adaptations, with the support of all stakeholders through all stages of the implementation.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"207-215"},"PeriodicalIF":5.2,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management. 青少年发病的 2 型糖尿病：病理生理学、预后、预防和管理概述。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-08-01 Epub Date: 2024-07-03 DOI: 10.1007/s11892-024-01546-2

Angela Titmuss, Sophy Korula, Brandy Wicklow, Kristen J Nadeau

{"title":"Youth-onset Type 2 Diabetes: An Overview of Pathophysiology, Prognosis, Prevention and Management.","authors":"Angela Titmuss, Sophy Korula, Brandy Wicklow, Kristen J Nadeau","doi":"10.1007/s11892-024-01546-2","DOIUrl":"10.1007/s11892-024-01546-2","url":null,"abstract":"Purpose of review: This review explores the emerging evidence regarding pathogenesis, future trajectories, treatment options, and phenotypes of youth-onset type 2 diabetes (T2D).Recent findings: Youth-onset T2D is increasing in incidence and prevalence worldwide, disproportionately affecting First Nations communities, socioeconomically disadvantaged youth, and people of colour. Youth-onset T2D differs in pathogenesis to later-onset T2D and progresses more rapidly. It is associated with more complications, and these occur earlier. While there are limited licensed treatment options available, the available medications also appear to have a poorer response in youth with T2D. Multiple interacting factors likely contribute to this rising prevalence, as well as the increased severity of the condition, including structural inequities, increasing obesity and sedentary lifestyles, and intergenerational transmission from in-utero exposure to maternal hyperglycemia and obesity. Youth-onset T2D is also associated with stigma and poorer mental health, and these impact clinical management. There is an urgent need to develop effective interventions to prevent youth-onset T2D and enhance engagement of affected youth. It is also critical to better understand the differing phenotypes of youth-onset T2D, to effectively target treatments, and to address intergenerational transmission in high-risk populations.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"183-195"},"PeriodicalIF":5.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11269415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Review Article - Diabetes Technology in the Hospital: An Update. 评论文章--医院中的糖尿病技术：最新进展。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-08-01 Epub Date: 2024-06-06 DOI: 10.1007/s11892-024-01545-3

Margaretha M Visser, Roman Vangoitsenhoven, Pieter Gillard, Chantal Mathieu

{"title":"Review Article - Diabetes Technology in the Hospital: An Update.","authors":"Margaretha M Visser, Roman Vangoitsenhoven, Pieter Gillard, Chantal Mathieu","doi":"10.1007/s11892-024-01545-3","DOIUrl":"10.1007/s11892-024-01545-3","url":null,"abstract":"Purpose of review: There have been many developments in diabetes technology in recent years, with continuous glucose monitoring (CGM), insulin pump therapy (CSII) and automated insulin delivery (AID) becoming progressively accepted in outpatient diabetes care. However, the use of such advanced diabetes technology in the inpatient setting is still limited for several reasons, including logistical challenges and staff training needs. On the other hand, hospital settings with altered diet and stress-induced hyperglycemia often pose challenges to tight glycemic control using conventional treatment tools. Integrating smarter glucose monitoring and insulin delivery devices into the increasingly technical hospital environment could reduce diabetes-related morbidity and mortality. This narrative review describes the most recent literature on the use of diabetes technology in the hospital and suggests avenues for further research.Recent findings: Advanced diabetes technology has the potential to improve glycemic control in hospitalized people with and without diabetes, and could add particular value in certain conditions, such as nutrition therapy or perioperative management. Taken together, CGM allows for more accurate and patient-friendly follow-up and ad hoc titration of therapy. AID may also provide benefits, including improved glycemic control and reduced nursing workload. Before advanced diabetes technology can be used on a large scale in the hospital, further research is needed on efficacy, accuracy and safety, while implementation factors such as cost and staff training must also be overcome.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"173-182"},"PeriodicalIF":5.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141260444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Metabolic dysfunction-associated steatotic liver disease and atherosclerosis. 代谢功能障碍与脂肪肝和动脉粥样硬化有关。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-07-01 Epub Date: 2024-05-03 DOI: 10.1007/s11892-024-01542-6

Yulino Castillo-Núñez, Paloma Almeda-Valdes, Guillermo González-Gálvez, María Del Rosario Arechavaleta-Granell

{"title":"Metabolic dysfunction-associated steatotic liver disease and atherosclerosis.","authors":"Yulino Castillo-Núñez, Paloma Almeda-Valdes, Guillermo González-Gálvez, María Del Rosario Arechavaleta-Granell","doi":"10.1007/s11892-024-01542-6","DOIUrl":"10.1007/s11892-024-01542-6","url":null,"abstract":"Purpose of review: To update information about the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and atherosclerosis. This review emphasizes the potential mechanisms linking MASLD with atherosclerosis and the possible causal relationships between these conditions.Recent findings: An increased risk of cardiovascular disease is related to MASLD. Several molecular, cellular, and metabolic mechanisms have been described to explain the development of atherothrombosis in MASLD patients. These include atherogenic dyslipidemia, low-grade vascular inflammation, endothelial dysfunction, foam cell formation, proliferation of vascular smooth muscle cells, insulin resistance, gut microbiota dysbiosis, activation of renin-angiotensin and sympathetic nervous systems, hypercoagulability, and decreased fibrinolysis. Also, there is recent evidence suggesting an association between genetically driven liver fat and coronary heart disease mediated by the causal effect of apoB-containing lipoproteins. Several meta-analyses and systematic reviews have reported a strong association between MASLD and cardiovascular outcomes. MASLD is an important and independent risk factor for atherosclerosis development. Multiple mechanisms may be involved in this association. Further research is required to establish a causal association between MASLD and atherosclerosis.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"158-166"},"PeriodicalIF":5.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Exploring the Interplay between Diabetes and Lp(a): Implications for Cardiovascular Risk. 探索糖尿病与脂蛋白（a）之间的相互作用：对心血管风险的影响。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-07-01 Epub Date: 2024-05-28 DOI: 10.1007/s11892-024-01543-5

Corral Pablo, Arrupe Matías, Augusto Lavalle Cobo, Gimenez Sergio, Renna Nicolás Federico

{"title":"Exploring the Interplay between Diabetes and Lp(a): Implications for Cardiovascular Risk.","authors":"Corral Pablo, Arrupe Matías, Augusto Lavalle Cobo, Gimenez Sergio, Renna Nicolás Federico","doi":"10.1007/s11892-024-01543-5","DOIUrl":"10.1007/s11892-024-01543-5","url":null,"abstract":"Purpose of review: The objective of this manuscript is to review and describe the relationship between Lp(a) and diabetes, exploring both their association and synergy as cardiovascular risk factors, while also describing the current evidence regarding the potential connection between low levels of Lp(a) and the presence of diabetes.Recent findings: Epidemiological studies suggest a potential relationship between low to very low levels of Lp(a) and diabetes. Lipoprotein(a), or Lp(a), is an intriguing lipoprotein of genetic origin, yet its biological function remains unknown. Elevated levels of Lp(a) are associated with an increased risk of cardiovascular atherosclerosis, and coexisting diabetes status confers an even higher risk. On the other hand, epidemiological and genetic studies have paradoxically suggested a potential relationship between low to very low levels of Lp(a) and diabetes. While new pharmacological strategies are being developed to reduce Lp(a) levels, the dual aspects of this lipoprotein's behavior need to be elucidated in the near future.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"167-172"},"PeriodicalIF":5.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Social and Structural Determinants of Cardiovascular Complications of Diabetes 糖尿病心血管并发症的社会和结构决定因素

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2024-05-02 DOI: 10.1007/s11892-024-01541-7

Portia Mensah, Kelly Valdez, Ankita Gyawali, Janet Snell-Bergeon

{"title":"Social and Structural Determinants of Cardiovascular Complications of Diabetes","authors":"Portia Mensah, Kelly Valdez, Ankita Gyawali, Janet Snell-Bergeon","doi":"10.1007/s11892-024-01541-7","DOIUrl":"https://doi.org/10.1007/s11892-024-01541-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3>Cardiovascular disease (CVD) is the leading cause of mortality in people who have diabetes. Racial and ethnic minorities with diabetes have suboptimal management of cardiovascular risk factors, leading to higher mortality. Social and structural determinants of health are external factors that influence an individual’s ability to choose positive health behaviors. In this review, we will discuss cardiovascular complications in people who have diabetes and their relationship to social determinants of health (SDOH).<h3 data-test=\"abstract-sub-heading\">Recent Findings</h3>Recent innovations in diabetes treatment, including new devices and medications, have improved care and survival. However, disparities in the availability of these treatments to racial and ethnic minorities may contribute to continued inequities in CVD outcomes.<h3 data-test=\"abstract-sub-heading\">Summary</h3>Racial/ethnic disparities in CVD relate to inequities in economic opportunity, education and health literacy, neighborhoods and social cohesion, and health care access and quality driven by structural racism.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"88 1","pages":""},"PeriodicalIF":4.2,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140831725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diabetes Technology in People with Type 2 Diabetes: Novel Indications. 2 型糖尿病患者的糖尿病治疗技术：新适应症。

IF 4.2 2区医学

Current Diabetes Reports Pub Date : 2024-05-01 Epub Date: 2024-02-29 DOI: 10.1007/s11892-024-01536-4

Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu

{"title":"Diabetes Technology in People with Type 2 Diabetes: Novel Indications.","authors":"Shubham Agarwal, Rodolfo J Galindo, Amy V Shah, Marconi Abreu","doi":"10.1007/s11892-024-01536-4","DOIUrl":"10.1007/s11892-024-01536-4","url":null,"abstract":"Purpose of review: Diabetes technology has been continuously evolving. Current versions of continuous glucose monitors (CGM) use minimally invasive designs, monitor glucose values with high accuracy, and can be used to guide insulin dosing. Extensive evidence supports the use of diabetes technology for monitoring and insulin administration in people with type 1 diabetes. However, there is emerging evidence for people with type 2 diabetes. In this review, we present the different technological devices used to monitor glucose and deliver insulin and the evidence supporting their use in people with type 2 diabetes.Recent findings: The use of CGMs in people with type 2 diabetes treated with insulin or non-insulin therapies has been associated with improvements in glycemic control and time spent in hypoglycemia. Smart insulin pens and smart connected devices are options to track compliance and guide insulin delivery in people who do not require insulin pump therapy. Mechanical patch pumps can be used to reduce the burden of multiple daily insulin injections. Automated insulin delivery algorithms improve glycemic control without an increase in hypoglycemia. The use of technology in the management of type 2 diabetes generates glycemic data previously inaccessible, reduces barriers for insulin initiation, improves glycemic control, tracks adherence to therapy, and improves user satisfaction.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"85-95"},"PeriodicalIF":4.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Use of Online Communities among People with Type 2 Diabetes: A Scoping Review. 2 型糖尿病患者使用网络社区的情况：范围综述。

IF 5.2 2区医学

Current Diabetes Reports Pub Date : 2024-05-01 Epub Date: 2024-03-08 DOI: 10.1007/s11892-024-01538-2

Arantxa Bujanda-Sainz de Murieta, Nelia Soto-Ruiz, Cristina García-Vivar, Leticia San Martín-Rodríguez, Paula Escalada-Hernández

{"title":"Use of Online Communities among People with Type 2 Diabetes: A Scoping Review.","authors":"Arantxa Bujanda-Sainz de Murieta, Nelia Soto-Ruiz, Cristina García-Vivar, Leticia San Martín-Rodríguez, Paula Escalada-Hernández","doi":"10.1007/s11892-024-01538-2","DOIUrl":"10.1007/s11892-024-01538-2","url":null,"abstract":"Purpose of review: People with diabetes require continuous self-monitoring and face numerous decisions in their day-to-day lives. Therefore, on many occasions, they need more support than that provided by health professionals. In this context, peer support in online diabetes communities could be a useful tool. The purpose of the review is to describe, analyze and synthesize the available evidence on the use and health out-comes of online communities for people with type 2 diabetes mellitus. A scoping review was conducted in accordance with the Joanna Briggs Institute guidelines. Searches were performed PubMed, Web of Science, CINHAL, Scopus and Cochrane databases.Recent findings: From 1821 identified documents, 6 articles were included. These studies explored the characteristics of diabetes online communities and the population features. Besides, the results were classified according to whether they were clinical, psychosocial, or addressed people's experiences with the online community. The analysis underscores their value in facilitating communication, improving diabetes management, and enhancing psychosocial well-being. Future investigations should prioritize longitudinal assessments to elucidate the sustained impact of community engagement and optimize user participation for enhanced patient outcomes. The growing relevance of new technologies has led to a significant number of individuals with chronic illnesses seeking peer support. Online health communities have emerged as virtual spaces where individuals with shared health interests interact and form relationships. Within these digital spaces, individuals can engage in peer interaction, observe behaviors, and mutually benefit, potentially leading to improved attitudes toward the disease.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":" ","pages":"96-107"},"PeriodicalIF":5.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0